About Us: Bridging Sectors. Catalyzing Impact.
Strengthening the Global Health Ecosystem
The Alliance for Innovation in Global Health, formerly the Bay Area Global Health Alliance, strengthens the global health ecosystem by catalyzing cross-sector collaboration and accelerating the flow of innovation, capital, and partnerships to advance health equity and improve outcomes worldwide.
In an era of constrained resources and growing complexity, we help organizations navigate rapid change and accomplish more together than they could alone, achieving greater health impact where it is needed most.
Headquartered in Silicon Valley and connected globally, the Alliance is a cross-sector membership network of more than 110 organizations, with a distinctive concentration of technology, private sector, and low- and middle-income country (LMIC) members. This composition gives us an uncommon ability to bridge communities that rarely work together—connecting innovation with implementation, technology with public health, global expertise with local leadership, and promising ideas with the partners and resources needed to move them toward impact.
How We Create Value
As a trusted, neutral platform, the Alliance creates the conditions for meaningful cross-sector collaboration. Through strategic convenings, curated connections, collective intelligence, and actionable insights, we help organizations navigate complexity, build trusted relationships, identify new opportunities, and move ideas toward action.
Convenings
Bringing leaders across sectors together for candid dialogue, shared learning, and opportunities for action.
Connections and Partnerships
Bridging organizations, expertise, and resources to build relationships and catalyze new partnerships.
Collective Intelligence and Amplification
Connecting diverse perspectives to help organizations navigate change and make better decisions—and extending important ideas and insights across the global health ecosystem.
Community
Fostering a trusted cross-sector community that strengthens relationships, shared learning, and the broader ecosystem.
Snapshot of Membership
Our distinctive membership enables the Alliance to bridge communities that rarely work together and build the relationships and connective infrastructure that help the global health ecosystem function more effectively.
organizations across sectors and geographies
%
technology and digital innovation
%
private sector
%
based in low- and middle-income countries
After six years of growth, the Bay Area Global Health Alliance has become the Alliance for Innovation in Global Health. The new name reflects our evolution from a Bay Area network into a global cross-sector alliance of more than 110 organizations—and a clearer role bridging organizations and sectors to accelerate innovation and impact.
Alliance Programming & Initiatives
AI and Global Health
The intersection of AI and global health is unlocking new possibilities to improve health outcomes, expand access, and address persistent challenges across health systems worldwide. Building on momentum from our 2023 Annual Meeting panel and our participation in the White House Office of Science and Technology Policy (OSTP) Roundtable on AI and Global Health, our community has voiced a strong interest in continuing to shape this fast-evolving frontier. At the Alliance, we are convening cross-sector leaders to explore how AI can be responsibly and effectively applied to global health.
Innovative Financing and Investments
As traditional global health funding faces mounting challenges, private capital, impact investing, and innovative financing are increasingly critical. In alignment with our mission, the Alliance is fostering multi-sector dialogues to catalyze greater private-sector investment in healthcare across emerging markets. Our programming—including convenings at the J.P. Morgan Healthcare Conference, the Rockefeller Foundation’s Bellagio Center, and outcomes-based financing efforts targeting antimicrobial resistance—is helping shape the future of sustainable global health financing.
At a time when global health is rethinking old models, the Alliance community asked a sharper question: what must we build next? On May 28, the Alliance convened its multisector community in San Francisco and online for a members-only gathering that created space for candid, provocative conversation about the future of global health — from the role of technology and power, to the shift from market shaping to market building, to the trusted partnerships needed to navigate change. The program included a fireside chat with keynote speaker Raffi Krikorian, CTO of Mozilla and a focused cross-sector panel discussion on market shaping in a fractured era with leaders from Access to Medicine Foundation, inSupply Health, Roche Diagnostics, Vital Strategies, and The Partnership Lab.
AI’s Biggest Risk Isn’t the Technology — It’s Who Controls It, Raffi Krikorian Tells Alliance Annual Meeting
At the Alliance’s 2026 Annual Meeting, Krista Donaldson, Alliance board member and director of innovation to impact at Stanford Biodesign, moderated a fireside conversation with Raffi Krikorian, chief technology officer at Mozilla and board chair at Mozilla.ai and Medic, exploring how global health leaders should think about technology, power, and responsibility in the age of artificial intelligence (AI).
From Market Shaping to Market Building: What Happens When the Old Global Health Playbook No Longer Applies?
At the Alliance’s 2026 Annual Meeting, a panel moderated by Jessica Katz, founder and CEO of The Partnership Lab, brought together Yasmin Chandani, CEO of inSupply Health; Jayasree Iyer, CEO of the Access to Medicine Foundation; Mary-Ann Etiebet, president and CEO of Vital Strategies; and Joanna Sickler, vice-president of health policy and external affairs at Roche Diagnostics to examine how market shaping is evolving into market building amid tighter funding, geopolitical shifts, growing country ownership, and more complex health markets.
AI Governance in Global Health: What It Means in Practice—and Why It Matters Now
On May 7, the Alliance convened leaders from HealthAI, Transform Health, and Vital Strategies for a candid conversation on what AI governance means in practice — and why it is quickly becoming central to whether AI strengthens health systems or deepens existing inequities. Co-moderated by Daniel Messer, chief digital and IT transformation officer at FHI 360, and Sara Anderson, executive director of the Alliance, the discussion focused not only on safeguards and regulation, but on the deeper infrastructure required for responsible and sustainable AI adoption.
Building Country-led Ecosystems to Scale Global Health Innovation
On April 30, the Alliance convened a focused discussion on ‘Building Country-led Ecosystems to Scale Global Health Innovation,’ bringing together leaders from Google Research Africa and Amp Health, moderated by eHealth Africa, to examine how locally rooted innovation ecosystems are being built — and what it takes to make them last. The conversation moved beyond theory: what it takes for governments to genuinely lead, how embedded support can build lasting capacity, and what the private sector’s role should — and shouldn’t — be. One insight that stayed with us: country-led innovation isn’t slower innovation. It’s more durable innovation.
Strategies and Pathways for Economic Viability for Scaling Health Innovations in Underserved Settings
As funding constraints reshape the global health landscape, innovators are facing an urgent question: how do they turn strong ideas and meaningful impact into a clear funding case that resonates with funders and investors? This question shaped a recent Innovation and Health Equity Discussion Series session, ‘Strategies and Pathways for Economic Viability for Scaling Health Innovations in Underserved Settings,’ hosted by Stanford Biodesign, in partnership with the Alliance and Baraka Impact Finance. James Bair, partner and managing director at Baraka Impact Finance, in conversation with Sara Anderson, executive director of the Alliance, offered practical guidance on how founders and innovators can position their ventures for funding, sustainability, and scale in a rapidly changing capital environment.
DFC Financing 101: What Global Health Leaders Need to Know
At a pivotal moment for global health financing, the Bay Area Global Health Alliance convened a members-only virtual deep dive with the U.S. International Development Finance Corporation (DFC) to help organizations better understand DFC’s mandate and assess whether their work aligns with the agency’s strategic priorities and financing tools. The DFC’s Nafisa Jiwani, Associate Vice President of Health Initiatives, and Monisha Ashok, Director of Health Investments, provided a clear overview of DFC’s investment criteria and strategic focus — along with practical guidance to help members evaluate potential fit and identify next steps for engagement.
JPM 2026 | From Products to Patients: Capturing Value in Asia and Africa’s Growth Markets
For the third consecutive year, the Alliance convened a panel at the 2026 J.P. Morgan Healthcare Conference (JPM) in San Francisco, followed by an Alliance side meeting held at Accenture’s San Francisco Innovation Hub. This year’s panel brought together leaders from Gilead Sciences, U.S. Development Finance Corporation (DFC), Nivi, Inc., reach52, and Accenture to explore how pharmaceutical partnerships, development finance, and patient platforms are creating investable infrastructure in high-growth markets across Asia and Africa. The panel underscored that the most promising long-term opportunities in emerging markets lie not just in individual products, but in the systems and partnerships that connect them to patients.
Report: Narrowing the Know-Do Gap, Exploring the Intersection of Implementation Science and Health Equity
Considerable advancements and significant investments in global health have marked recent years; yet numerous evidence-based interventions continue to fall short of their full potential. By leveraging the multidisciplinary and multi-sector strength of its members, the Bay Area Global Health Alliance explored these challenges through the lens of implementation science in our new insights report. The project engaged nearly 150 global health leaders across various disciplines and sectors to inform and enhance the design, implementation, and scalability of health solutions.
USG Policy Shifts and Impact on Global Health
Amid significant shifts in U.S. government policy affecting global health, the Alliance is working to meet this moment by curating timely policy updates and resources, advancing programming that supports innovation and sustainable financing, convening our cross-sector network through targeted roundtables to understand the implications, and fostering collaboration to help members navigate uncertainty and shape the future of global health.